Simplification Therapy with Once‐Daily Emtricitabine, Didanosine, and Efavirenz in HIV‐1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial
Jean‐Michel Molina(Assistance Publique – Hôpitaux de Paris), Cécile Goujard, Valérie Journot(Inserm), Willy Rozenbaum, Pierre Palmer(Assistance Publique – Hôpitaux de Paris), Fidéline Collin(Inserm), B. Dupont(Délégation Paris 5), P. Dellamonica, Geneviève Chêne(Bordeaux Population Health), Isabelle Poizot‐Martin(Hôpital Sainte-Marguerite), Philippe Morlat, Sandra Fournier(Assistance Publique – Hôpitaux de Paris), Patrick Yéni, Corinne Rancinan(Inserm), Laurence Morand‐Joubert(Assistance Publique – Hôpitaux de Paris)
Cited by 68
Related Papers
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Treatment for Adult HIV Infection
|JAMA|2006|1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k
Antiretroviral Therapy for HIV Infection in 1998
|JAMA|1998|1k